Patents by Inventor Cubist Pharmaceuticals, Inc.

Cubist Pharmaceuticals, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibiotic Compositions for the Treatment of Gram Negative Infections
    Publication number: 20140073559
    Abstract: Provided herein are novel compounds and novel protected compounds that can be derived from polymyxin, including, e.g., polymyxin A. The novel compounds have antibacterial properties against a diverse range of Gram negative bacteria and reduced toxicity compared to polymyxins such as polymyxin A. Also provided are antibacterial pharmaceutical compositions containing the novel compounds and novel protected compounds, as well as methods for preparing the antibacterial compounds and protected compounds.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 13, 2014
    Applicants: Cubist Pharmaceuticals, Inc., BioSource Pharm, Inc.
    Inventors: BioSource Pharm, Inc., Cubist Pharmaceuticals, Inc.
  • ISOXAZOLE BETA-LACTAMASE INHIBITORS
    Publication number: 20130345190
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Application
    Filed: March 29, 2013
    Publication date: December 26, 2013
    Inventor: Cubist Pharmaceuticals, Inc.